Oyama, T

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Feb 1998 - 1224-32 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0022-1767


Antigens, CD34--analysis
Cell Differentiation--drug effects
Cell-Free System--immunology
Cells, Cultured
DNA-Binding Proteins--pharmacology
Dendritic Cells--cytology
Endothelial Growth Factors--metabolism
Fetal Blood
Hematopoietic Stem Cells--drug effects
Humans
I-kappa B Proteins
Lymphokines--metabolism
NF-KappaB Inhibitor alpha
NF-kappa B--antagonists & inhibitors
Protein Binding--immunology
Proto-Oncogene Proteins--physiology
Receptor Protein-Tyrosine Kinases--physiology
Signal Transduction--immunology
Transcription, Genetic--drug effects
Tumor Cells, Cultured
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factors